Avita Medical, Inc.

Avita Medical, Inc.

3.50
USD
+0.17
(+5.11%)
-0.24EPS
301.74MMarket Cap
Feb 25Next Earn

Total Valuation

USD

As of September 30, 2026, Avita Medical, Inc. carries a market capitalization of 301.74M, placing it among publicly traded companies globally. Its enterprise value stands at 338.37M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap301.74M
Enterprise Value338.37M

Important Dates

Avita Medical, Inc.'s next confirmed earnings release is scheduled for February 25, 2027.

Earnings Date2/25/2027

Share Statistics

As of September 30, 2026, Avita Medical, Inc. has 150.87M shares outstanding.

Shares Outstanding150.87M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 3.53, and the price-to-book ratio stands at -9.72.

PS Ratio3.53
PB Ratio-9.72
P/TBV Ratio-8.25
P/FCF Ratio-15.43
P/OCF Ratio-15.14

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 4.00 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 338.37M versus a market cap of 301.74M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales4.00

Financial Position

As of September 30, 2026, Avita Medical, Inc. maintains a current ratio of 1.20, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -151.86, indicating conservative leverage, while an interest coverage ratio of -4.66 demonstrates limited ability to service its debt obligations.

Current Ratio1.20
Quick Ratio0.90
Debt / Equity-151.86
Debt / EBITDA-1.80
Interest Coverage-4.66

Financial Efficiency

USD

These figures cover the twelve months ended September 30, 2026. Return on assets (ROA) is negative at -65.36, reflecting losses generated across the asset base. The company generates approximately 374,699.12 in revenue per employee across its workforce of 226.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.48 indicates how many times Avita Medical, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-65.36
Revenue Per Employee374,699.12
Employee Count226.00
Inventory Turnover2.48

Taxes

USD

Over the twelve months ended September 30, 2026, Avita Medical, Inc. recorded 70,000.00 in income tax expense. The company reported a pretax loss of -36.05M and -36.12M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax70,000.00

Stock Price Statistics

USD

As of the close on November 11, 2026, Avita Medical, Inc.'s stock has gained approximately 213.90% over the past 52 weeks. The 50-day moving average sits at 1.39, while the 200-day moving average is 1.90.

52-Week Price Change213.90%
50-Day Moving Average1.39
200-Day Moving Average1.90

Income Statement

USD

Over the twelve months ended September 30, 2026, Avita Medical, Inc. generated 84.68M in revenue and converted that into -36.12M in net income, yielding earnings per share of -0.24. EBITDA reached -26.17M, while operating income came in at -28.69M.

Revenue84.68M
Gross Profit69.75M
Operating Income-28.69M
Pretax Income-36.05M
Net Income-36.12M
EBITDA-26.17M
EBIT-28.69M
Earnings Per Share (EPS)-0.24

Balance Sheet

USD

As of September 30, 2026, Avita Medical, Inc. holds 10.50M in cash and equivalents against 47.13M in total debt, resulting in a net debt position of 34.98M. Total book value stands at -31.04M, with working capital of 4.64M providing operational flexibility.

Cash & Cash Equivalents10.50M
Total Debt47.13M
Net Debt34.98M
Equity (Book Value)-31.04M
Book Value Per Share-0.21
Working Capital4.64M

Cash Flow

USD

Avita Medical, Inc. produced -19.72M in operating cash flow over the twelve months ended September 30, 2026. After subtracting 365,000.00 in capital expenditures, free cash flow totaled -19.35M - equivalent to -0.13 per share.

Operating Cash Flow-19.72M
Capital Expenditures365,000.00
Free Cash Flow-19.35M
FCF Per Share-0.13

Margins

Over the twelve months ended September 30, 2026, Avita Medical, Inc. posted a gross margin of 82.36, reflecting its pricing power and cost economics. The operating margin of -33.89 and net profit margin of -42.65 provide insight into operational efficiency.

Gross Margin82.36
Operating Margin-33.89
Pretax Margin-42.57
Profit Margin-42.65
EBITDA Margin-30.91

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -6.48: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.31, meaning Avita Medical, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-2.31
FCF Yield-6.48

Stock Splits

Avita Medical, Inc.'s most recent stock split took place on June 24, 2020 with a 20:1 split ratio.

Last Split Date6/24/2020
Split Ratio20:1

Scores

As of September 30, 2026, Avita Medical, Inc. has an Altman Z-Score of -12.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-12.48